Prime Medicine, Inc. (PRME) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $120.87M | -21.1% |
| 2024 | $153.15M | +15.1% |
| 2023 | $133.07M | -57.9% |
| 2022 | $316.27M | +302.4% |
| 2021 | -$156.24M | -6782.6% |
| 2020 | $2.34M | +190.0% |
| 2019 | -$2.60M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $120.87M | -21.1% |
| 2024 | $153.15M | +15.1% |
| 2023 | $133.07M | -57.9% |
| 2022 | $316.27M | +302.4% |
| 2021 | -$156.24M | -6782.6% |
| 2020 | $2.34M | +190.0% |
| 2019 | -$2.60M | — |